Skip to search formSkip to main contentSkip to account menu

Duavee

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Estrogens, Conjugated (USP)bazedoxifene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Announces FDA Approval of DUAVEE TM ( conjugated estrogens / bazedoxifene ) for the Treatment of Moderate-to-Severe Vasomotor Symptoms ( Hot Flashes ) Associated with Menopause and the Prevention of…
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE), a leader in the development of treatments for menopausal symptoms, is pleased… 
2013
2013
FDA Approves New Drug for Vasomotor Symptoms, Osteoporosis Prevention
The FDA has approved Duavee, the first medication to combine estrogen with bazedoxifene, for the treatment of hot flashes and the…